Literature DB >> 29980449

Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.

Hang Xu1, Ping Tan1, Jianzhong Ai1, Yu Huang1, Tianhai Lin1, Lu Yang2, Qiang Wei3.   

Abstract

PURPOSE: To identify the impact of albumin-globulin ratio (AGR) on pathologic and survival outcomes in patients with upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU). PATIENTS AND METHODS: We retrospectively reviewed medical records of 620 patients treated with RNU for UTUC at our institution. Logistic regression analysis was used to evaluate the relation between low AGR (<1.45) and adverse pathologic features. Kaplan-Meier curves were used to estimate recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) probabilities between 2 groups. Univariable and multivariable Cox regression models were performed to address prognostic factors related to RFS, CSS, and OS.
RESULTS: Of the 620 patients, 323 (52.1%) had AGR < 1.45. During a median follow-up of 50.0 months (interquartile range, 28-78 months), 277 (44.7%) experienced disease recurrence and 194 (31.3%) died of disease. The results showed that low AGR was significantly associated with adverse pathologic features (all P < .05). Kaplan-Meier analysis showed that compared to those with high AGR (≥1.45), patients with low AGR had poorer RFS, CSS, and OS (P < .001). After adjusting for the confounding clinicopathologic factors, multivariate analyses showed that AGR < 1.45 independently predicted poor RFS (hazard ratio [HR] = 1.321, P = .029), CSS (HR = 1.503, P = .010) and OS (HR = 1.403, P = .015).
CONCLUSION: Low preoperative AGR is an independent predictor of worse pathologic and oncologic outcomes in patients with UTUC after RNU. The application of AGR as an easily assessed blood-based biomarker in predicting the prognosis of patients with UTUC is promising.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albumin-globulin ratio; Prognosis; Radical nephroureterectomy; Upper tract urothelial carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29980449     DOI: 10.1016/j.clgc.2018.06.003

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  11 in total

1.  Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.

Authors:  Zihan Zhao; Shangxun Xie; Baofu Feng; Shiwei Zhang; Yifan Sun; Hongqian Guo; Rong Yang
Journal:  Cancer Manag Res       Date:  2020-09-25       Impact factor: 3.989

2.  Preoperative Inversed Albumin-to-Globulin Ratio Predicts Worse Oncologic Prognosis Following Curative Hepatectomy for Hepatocellular Carcinoma.

Authors:  Cheng-Cheng Zhang; Cheng-Wu Zhang; Hao Xing; Yu Wang; Lei Liang; Yong-Kang Diao; Ting-Hao Chen; Wan Yee Lau; Ping Bie; Zhi-Yu Chen; Tian Yang
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

Review 3.  Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma.

Authors:  Hyeong Dong Yuk; Ja Hyeon Ku
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 5.738

4.  Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.

Authors:  Hang Xu; Jian-Zhong Ai; Ping Tan; Tian-Hai Lin; Xi Jin; Li-Na Gong; Hao-Ran Lei; Lu Yang; Qiang Wei
Journal:  Asian J Androl       Date:  2020 Mar-Apr       Impact factor: 3.285

5.  Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients.

Authors:  Xiaoyan Wang; Guodong Yang; Yumeng Chai; Zhouyue Li; Xuanyan Che; Yongqiang Wang; Liqing Yang; Zhongbao Zhou
Journal:  Dis Markers       Date:  2022-09-05       Impact factor: 3.464

6.  Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma.

Authors:  Shota Omura; Satoru Taguchi; Shogo Miyagawa; Ryuki Matsumoto; Mio Samejima; Naoki Ninomiya; Kazuki Masuda; Yu Nakamura; Tsuyoshi Yamaguchi; Manami Kinjo; Mitsuhiro Tambo; Takatsugu Okegawa; Eiji Higashihara; Hiroshi Fukuhara
Journal:  BMC Urol       Date:  2020-08-28       Impact factor: 2.264

7.  Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma.

Authors:  Hang Xu; Ping Tan; Xi Jin; Jianzhong Ai; Tianhai Lin; Haoran Lei; Lu Yang; Qiang Wei
Journal:  Cancer Med       Date:  2018-11-28       Impact factor: 4.452

8.  Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study.

Authors:  Satoru Taguchi; Taketo Kawai; Tohru Nakagawa; Yu Nakamura; Jun Kamei; Daisuke Obinata; Kenya Yamaguchi; Tomoyuki Kaneko; Shigenori Kakutani; Mayuko Tokunaga; Yukari Uemura; Yusuke Sato; Tetsuya Fujimura; Hiroshi Fukuhara; Yutaka Enomoto; Hiroaki Nishimatsu; Satoru Takahashi; Haruki Kume
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

9.  Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Benjamin Pradere; David D'Andrea; Victor M Schuettfort; Beat Foerster; Fahad Quhal; Keiichiro Mori; Mohammad Abufaraj; Vitaly Margulis; Marine Deuker; Alberto Briganti; Tim Muilwijk; Kees Hendricksen; Yair Lotan; Pierre Karakiewic; Shahrokh F Shariat
Journal:  World J Urol       Date:  2020-10-16       Impact factor: 4.226

10.  The prognostic value of tumor architecture in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A systematic review and meta-analysis.

Authors:  Hu Zhao; Lijin Zhang; Bin Wu; Zhenlei Zha; Jun Yuan; Yuefang Jiang; Yejun Feng
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.